Key facts
- Notable investors include Guizhou Financial Holdings Group, Button Capital, Guiyang Venture Capital, KKM Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Sinorda Biomedicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Sinorda Biomedicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sinorda Biomedicine
Developer of biomedicine intends to advance innovative treatments for digestive diseases. The company focuses on the development and innovation of medicine and the industrialization of tumor immunotherapy through its medicine research and development system and medicine production lines in clinical trial stage.
- Sector
- Healthcare
- HQ
- Guiyang, China
- Founded
- 2010
- Employees
- 5
- Website
- sinorda.com/
- Ownership
- Privately Held (backing)
Sinorda Biomedicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sinorda Biomedicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sinorda Biomedicine in its N-PORT filings yet. We sweep new filings monthly.